Extra Strength Pain Reliever Acetaminophen Recalled for cGMP Deviations
Ultra Seal Corporation is recalling Extra Strength Pain Reliever (acetaminophen 500 mg) 2 tablet packets nationwide due to cGMP deviations. The recall affects Lot #AK9602 with expiration date 05/2022.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for cGMP deviations without reported illnesses or injuries. The recall is voluntary and precautionary in nature, addressing manufacturing process defects rather than a confirmed product hazard.
Plain-English summary
Ultra Seal Corporation is recalling Extra Strength (ES) Pain Reliever tablets containing 500 mg acetaminophen in 2 tablet packets. The recall was initiated on January 24, 2022, and covers approximately 297,050 packets distributed nationwide within the United States.
The recall is due to Current Good Manufacturing Practice (cGMP) deviations identified during manufacturing. The affected product is Lot #AK9602 with expiration date 05/2022.
This is a voluntary recall initiated by the firm. The FDA classified this recall as Class II. The recall was terminated on October 16, 2023. Consumers who have purchased this product should discontinue use and consult with a healthcare provider or pharmacist if they have questions.
The recalled product
- Product
- Extra Strength (ES) PAIN RELIEVER (acetaminophen 500 mg) 2 tablet packets, Manufactured by Ultratab Laboratories, Inc.
- Manufacturer
- Ultra Seal Corporation
- Affected units
- 297,050
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AK9602
- Exp. Date 05/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Terminator decongestant recalled for cGMP deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModeratePhysicians CARE Extra Strength Pain Reliever recalled for CGMP deviations
FDA (Drugs) · 2022-01-26
- ModerateExtra-Strength Unaspirin Caplet Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16
- LowUltra Seal Recalls Pain Relief Tablets Due to Stability Failures
FDA (Drugs) · 2020-08-26
- ModerateExtra Strength Headache tablets recalled for CGMP manufacturing deviations
FDA (Drugs) · 2022-01-26
- LowUltra Seal Recalls Extra Strength Headache Relief Tablets for Stability Failures
FDA (Drugs) · 2020-08-26
- CriticalMedline Recalls Mislabeled Acetaminophen Extra-Strength Pain Reliever Tablets
FDA (Drugs) · 2016-02-24